Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)
Study Details
Study Description
Brief Summary
Cardiovascular disease is the leading cause of death in the United States. Other studies have shown that stress, early in life, could be a risk factor for cardiovascular disease, later in life. This study will look at the effect of early life stressors on your cardiovascular health.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
This study will have two parts involved to investigate the role that childhood SES status has on cardiovascular health.
Part one: Subjects will give a blood sample which will be processed and analyzed. Flow mediated dilation (FMD) and Pulse wave velocity (PWV/PWA) will be performed at baseline and 2 hours following either a single dose oral antioxidant cocktail (1000 mg of Vitamin C, 600 IU of Vitamin E, and 600 mg of alpha-lipoic acid) or placebo on two days separated by at least 72 hours. Nitroglycerin mediated dilation (NMD, 0.4mg sub-lingual nitroglycerin spray), will be assessed at baseline.
Part two: Subjects, if interested will undergo a subcutaneous gluteal/hip fat biopsy. Micro vessels will be isolated from the adipose tissue and analyzed by pressurized myography for endothelial function and nitric oxide bioavailability.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Antioxidant Cocktail Following an overnight fast, blood samples, flow-mediated dilation, and nitroglycerin mediated dilation (NMD; 0.4mg sub-lingual nitroglycerin spray) will be performed at baseline and 2 hours following either a single dose oral antioxidant cocktail (1000 mg Vitamin C, 600 IU vitamin E, 600 mg Alpha Lipoic Acid) or placebo on two days separated by at least 72 hours. |
Dietary Supplement: Antioxidant cocktail
Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment
Other Names:
Other: Placebo
Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment
Drug: NMD; 0.4mg sub-lingual nitroglycerin spray
Nitroglycerin mediated dilation will be measured immediately following an administered 0.4mg dose of nitroglycerin spray, sub-lingual.
Other Names:
|
Other: Biopsy Following an overnight fast, a subcutaneous gluteal/hip fat biopsy sample will be obtained from each subject under local anesthesia, with adipose tissue (~2x1.5x1.5cm) to be harvested and placed immediately in physiological saline solution (PSS): Small arteries, 100 to 150 um in diameter, will be dissected from the fat under a dissecting microscope, transferred to an arteriographic bath chamber, and cannulated for pressurized myography. |
Other: Biopsy
Under sterile conditions, a small incision (¼ - ½ inch) by the study doctor will be made and the piece of fat will be taken out. Fat tissue was chosen for this study because it is a big source of small blood vessels which we are studying
|
Outcome Measures
Primary Outcome Measures
- Acute Change in Flow mediated dilation [Change from baseline (2 hours)]
Flow-Mediated Dilation will be determined at baseline and 2 hours following acute antioxidant treatment
Secondary Outcome Measures
- Acute Change in Biomarkers of oxidative stress [Change from baseline (2 hours)]
Nitrite/nitrate, antioxidant capacity, and 8-isoprostane at baseline and 2 hours following acute antioxidant treatment
- Acute Change in Arterial Stiffness [Change from baseline (2 hours)]
Pulse wave velocity will be determined at baseline and 2 hours following acute antioxidant treatment
- Acute change in Flow mediated dilation [Immediate]
Nitroglycerin mediated dilation will be measured immediately following an administered 0.4mg dose of nitroglycerin spray, sub-lingual.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
documented childhood SES
-
men and premenopausal women ages 18-40
-
lean/overweight/or obese with BMI< or equal to 39kg/m2
Exclusion Criteria:
-
cardiovascular, renal, pulmonary, hepatic, cerebral, or metabolic,disease
-
use medications that affect vascular tone
-
post menopausal women
-
have class 3 obesity or BMI over 40
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Georgia Prevention Institute , Georgia Regents University | Augusta | Georgia | United States | 30912 |
Sponsors and Collaborators
- Augusta University
- National Heart, Lung, and Blood Institute (NHLBI)
Investigators
- Principal Investigator: Ryan Harris, PhD, Augusta University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NO-Stress Pro00001887
- 5P01HL069999